Wang, Xin, et al. “Comparison of Effectiveness and Safety Outcomes of Abiraterone Versus Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis: Abiraterone Versus Enzalutamide in MCRPC”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 23, Nov. 2020, pp. 451-6, doi:10.18433/jpps31003.